SEC23A and cancer: We report that SEC23A mRNA expression is associated with the overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) in some cancers such as adrenocortical carcinoma, bladder urothelial carcinoma (BLCA), cervical cancer, kidney renal papillary cell carcinoma, and uveal melanoma.